CClinicalTrials.gg
Status unknownNCT04382534Updated May 11, 2020

A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction

An observational study in Covid19, Respiratory Rehabilitation and Cross-sectional Study, sponsored by Peking University Third Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2020-05-11.

Sponsored by Peking University Third Hospital · Observational

The sponsor has not verified this record recently (last verified Apr 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Post-discharge rehabilitation regimens for covid-19 patients have not been supported by high-quality evidence-based medical evidence.The first part of this study is a cross-sectional study.The contents of the study were the factors related to the dysfunction of COVID - 19 patients after discharge from the hospital in Wuhan.The second part of this study is a cohort study.To observe the functional changes of COVID-19 patients after discharge in hospital rehabilitation, home rehabilitation and no rehabilitation, in order to propose a more safe and effective rehabilitation program.

02

Conditions studied

  • Covid19
  • Respiratory Rehabilitation
  • Cross-sectional Study
  • Cohort Study

Browse trials for

03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's planned enrollment of 300 is above the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Peking University Third Hospital is the lead sponsor of 735 studies on the registry; 262 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with COVID-19 after discharge

Inclusion criteria

  • patients with definite diagnosis of COVID-19 normal or severe
  • patients who entered the isolation point \<3 days after discharge
  • 18-80 years old
  • agree to join the queue

Exclusion criteria

Exclusion Criteria:

  • body temperature >38°C
  • heart rate >120 times/min or \<40 times/min, systolic blood pressure \<90mmHg or >180mmHg, respiratory rate >25 times/min in calm state.Or above vital signs fluctuate significantly.
  • continuous oxygen therapy is required.
  • patients with myocarditis, pulmonary hypertension, congestive heart failure, fresh venous thromboembolic diseases, unstable fractures and other inappropriate exercise
  • patients with consciousness disorders, severe sequelae of cerebral infarction, cognitive dysfunction, mental disorders, severe balance disorders, and severe bone and joint diseases, which affect evaluation and treatment
  • other conditions that cannot be cooperated with rehabilitation treatment
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • Rehabilitation guidance group

    1 to 2 times of rehabilitation instruction according to the rehabilitation instruction program, either online or in person.According to the rehabilitation instruction, the patient performed self-rehabilitation exercises in the isolation point.

  • Systematic rehabilitation treatment

    According to the systematic rehabilitation treatment program, the rehabilitation therapist entered the home for one-to-one rehabilitation treatment, once a day, for a total of 10 days.

    Combination Product: Respiratory rehabilitation

Interventions

  • Combination productRespiratory rehabilitation

    Health education and energy saving techniques, chest activity training, local lung dilation techniques, breathing training, airway clearance training, aerobic exercise, resistance training

06

What researchers measure

Primary outcomes

  1. Symptoms and signs

    To take a history and physical examination

    Time frame: Ten days

  2. Respiratory function

    To take a physical examination and mMRC

    Time frame: Ten days

  3. The body function

    To take a MMT, 6-min walking test and Borg Index

    Time frame: Ten days

  4. ADL

    To take a modified Barthel index

    Time frame: Ten days

07

Study locations

1 of 1 sites recruiting
  • Huarunwugang general hospital
    Wuhan, Hubei, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04382534
Lead sponsor
Peking University Third Hospital
Responsible party
Sponsor
First posted
May 11, 2020
Start date
Mar 10, 2020
Primary completion
Sep 30, 2020 (estimated)
Completion
Dec 31, 2020 (estimated)
Last update
May 11, 2020

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion